9780309993821 - Aligning Investments in Therapeutic Development with Therapeutic Need: Closing the Gap by National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board of Health Care Services; Committee on Strategies to Better Align Investments in Innovations for Therapeutic Development with Disease Burden and Unmet Needs (18 results)
- Softcover
Seller: Books From California, Simi Valley, CA, U.S.A.Books From California
Contact seller4-star sellerCondition: Used - Fine
US$ 5.00
US$ 4.99 shippingShips within U.S.A.Quantity: 7 available
paperback. Condition: Fine.
- Softcover
Seller: Books From California, Simi Valley, CA, U.S.A.Books From California
Contact seller4-star sellerCondition: Used - Very good
US$ 5.00
US$ 4.99 shippingShips within U.S.A.Quantity: 2 available
paperback. Condition: Very Good. Cover and edges may have some wear.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
US$ 28.16
US$ 2.64 shippingShips within U.S.A.Quantity: 3 available
Condition: New.
Aligning Investments in Therapeutic Development with Therapeutic Need
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Seller: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US
Contact seller5-star sellerCondition: New
US$ 30.81
Free ShippingShips within U.S.A.Quantity: 2 available
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
US$ 29.53
US$ 2.64 shippingShips within U.S.A.Quantity: 3 available
Condition: As New. Unread book in perfect condition.
Aligning Investments in Therapeutic Development with Therapeutic Need
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Seller: PBShop.store UK, Fairford, GLOS, United KingdomPBShop.store UK
Contact seller5-star sellerCondition: New
US$ 29.73
US$ 5.59 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
- Softcover
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail
Contact seller5-star sellerCondition: New
US$ 37.16
Free ShippingShips within U.S.A.Quantity: 1 available
Paperback. Condition: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment… in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Softcover
Seller: Chiron Media, Wallingford, United KingdomChiron Media
Contact seller5-star sellerCondition: New
US$ 25.54
US$ 20.83 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
paperback. Condition: New.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: New
US$ 28.99
US$ 20.17 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
Condition: New.
- Softcover
Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
US$ 31.34
US$ 20.17 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Paperback. Condition: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: Used - As new
US$ 31.88
US$ 20.17 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
Condition: As New. Unread book in perfect condition.
- Softcover
Seller: THE SAINT BOOKSTORE, Southport, United KingdomTHE SAINT BOOKSTORE
Contact seller5-star sellerCondition: New
US$ 33.17
US$ 21.52 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Paperback / softback. Condition: New. New copy - Usually dispatched within 3 working days.
- Softcover
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrelandKennys Bookshop and Art Galleries Ltd.
Contact seller5-star sellerCondition: New
US$ 43.63
US$ 12.00 shippingShips from Ireland to U.S.A.Quantity: 2 available
Condition: New. 2025. paperback. . . . . .
- Softcover
Seller: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contact seller5-star sellerCondition: New
US$ 51.29
US$ 10.50 shippingShips within U.S.A.Quantity: 2 available
Condition: New. 2025. paperback. . . . . . Books ship from the US and Ireland.
- Softcover
Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
US$ 54.96
US$ 20.17 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
- Softcover
Seller: CitiRetail, Stevenage, United KingdomCitiRetail
Contact seller5-star sellerCondition: New
US$ 33.91
US$ 49.75 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment… in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
- Softcover
Seller: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contact seller5-star sellerCondition: New
US$ 58.66
US$ 37.00 shippingShips from Australia to U.S.A.Quantity: 1 available
Paperback. Condition: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment… in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
US$ 41.37
US$ 70.77 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. Neuware - The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investmen…t in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.
